Abstract
Infection with SARS-CoV-2 frequently commences in the nasal cavity, yet knowledge about this initial virus-host interaction is sparse. In this review, we update our current understanding of SARS-CoV-2 infection via the nasal epithelium and the associated local immune response. Furthermore, we present considerations to how this interaction may influence the clinical course of COVID-19 and the systemic immune response, and lastly touch upon the potential for intranasal vaccination, intranasal antiviral therapies and immunomodulatory approaches
Bidragets oversatte titel | The nose can be the focus of treatment and prophylactic approaches against COVID-19 |
---|---|
Originalsprog | Dansk |
Artikelnummer | V05210442 |
Tidsskrift | Ugeskrift for Læger |
Vol/bind | 183 |
Nummer | 2 |
Antal sider | 9 |
ISSN | 0041-5782 |
Status | Udgivet - jan. 2022 |